| Bioactivity | CP320626 is a potent inhibitor of human liver glycogen phosphorylase (IC50=205 nM). CP320626 reduces blood glucose in diabetic mice without changing plasma insulin levels. CP320626 can be used in the study of type 2 diabetes[1]. |
| CAS | 186430-23-9 |
| Formula | C23H23ClFN3O3 |
| Molar Mass | 443.90 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Oikonomakos, et al. A new allosteric site in glycogen phosphorylase b as a target for drug interactions. Structure 8.6 (2000): 575-584. |
CP320626
CAS: 186430-23-9 F: C23H23ClFN3O3 W: 443.90
CP320626 is a potent inhibitor of human liver glycogen phosphorylase (IC50=205 nM). CP320626 reduces blood glucose in di
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.